Regent Peak Wealth Advisors LLC Amgen Inc Transaction History

Regent Peak Wealth Advisors LLC

$428 Million
Q1 2025

A detailed history of Regent Peak Wealth Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Regent Peak Wealth Advisors LLC holds 2,201 shares of AMGN stock, worth $645,839. This represents 0.16% of its overall portfolio holdings.

Number of Shares

2,201

Previous 2,790 21.11%

Holding current value

$645,839

Previous $727,000 5.78%

% of portfolio

0.16%

Previous 0.16%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 14, 2025	SELL	$258.59 - $327.36 $152,309 - $192,815	-589 Reduced 21.11%	2,201 $685,000
Q4 2024 Jan 07, 2025	SELL	$258.78 - $328.31 $1.43 Million - $1.81 Million	-5,525 Reduced 66.45%	2,790 $727,000
Q3 2024 Oct 16, 2024	SELL	$309.38 - $337.38 $220,587 - $240,551	-713 Reduced 7.9%	8,315 $2.68 Million
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $142,410 - $173,066	542 Added 6.39%	9,028 $2.82 Million
Q1 2024 May 01, 2024	SELL	$268.87 - $324.56 $310,007 - $374,217	-1,153 Reduced 11.96%	8,486 $2.41 Million
Q4 2023 Jan 23, 2024	SELL	$255.7 - $288.46 $45,514 - $51,345	-178 Reduced 1.81%	9,639 $2.78 Million
Q3 2023 Nov 03, 2023	SELL	$218.65 - $271.46 $5,028 - $6,243	-23 Reduced 0.23%	9,817 $2.64 Million
Q2 2023 Jul 19, 2023	BUY	$214.27 - $253.37 $21,855 - $25,843	102 Added 1.05%	9,840 $2.18 Million
Q1 2023 Apr 24, 2023	SELL	$225.79 - $275.2 $100,928 - $123,014	-447 Reduced 4.39%	9,738 $2.35 Million
Q4 2022 Feb 08, 2023	BUY	$229.03 - $291.01 $83,595 - $106,218	365 Added 3.72%	10,185 $2.67 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $32,546 - $36,706	145 Added 1.5%	9,820 $2.21 Million
Q2 2022 Aug 11, 2022	BUY	$230.71 - $256.74 $64,598 - $71,887	280 Added 2.98%	9,675 $2.35 Million
Q1 2022 May 03, 2022	BUY	$219.27 - $242.57 $250,187 - $276,772	1,141 Added 13.82%	9,395 $2.27 Million
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $1.27 Million - $1.46 Million	6,400 Added 345.2%	8,254 $1.86 Million
Q3 2021 Nov 08, 2021	SELL	$212.27 - $248.7 $40,543 - $47,501	-191 Reduced 9.34%	1,854 $394,000
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $1.39 Million - $1.54 Million	-5,955 Reduced 74.44%	2,045 $494,000
Q1 2021 Apr 28, 2021	BUY	$221.91 - $258.6 $248,761 - $289,890	1,121 Added 16.3%	8,000 $1.99 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $61,235 - $72,920	283 Added 4.29%	6,879 $1.58 Million
Q3 2020 Nov 04, 2020	BUY	$234.65 - $260.95 $99,022 - $110,120	422 Added 6.84%	6,596 $1.68 Million
Q2 2020 Aug 05, 2020	BUY	$197.81 - $242.74 $12,857 - $15,778	65 Added 1.06%	6,174 $1.46 Million
Q1 2020 Apr 27, 2020	BUY	$182.24 - $241.7 $40,092 - $53,174	220 Added 3.74%	6,109 $1.24 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $1.11 Million - $1.43 Million	5,889 New	5,889 $1.42 Million

Others Institutions Holding AMGN

# of Institutions

3,310

Shares Held

429M

Call Options Held

8.06M

Put Options Held

7.7M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $157B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Regent Peak Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regent Peak Wealth Advisors LLC with notifications on news.

Account

Regent Peak Wealth Advisors LLC Amgen Inc Transaction History